<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.5.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art550.dtd?><?SourceDTD.Version 5.5.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_LANCET4039 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEgr4 jpg ?><?FILEsi1 gif ?><front><journal-meta><journal-id journal-id-type="nlm-ta">Lancet</journal-id><journal-id journal-id-type="iso-abbrev">Lancet</journal-id><journal-title-group><journal-title>Lancet (London, England)</journal-title></journal-title-group><issn pub-type="ppub">0140-6736</issn><issn pub-type="epub">1474-547X</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5735217</article-id><article-id pub-id-type="publisher-id">S0140-6736(17)32092-5</article-id><article-id pub-id-type="doi">10.1016/S0140-6736(17)32092-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Local, national, and regional viral haemorrhagic fever pandemic potential in Africa: a multistage analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pigott</surname><given-names>David M</given-names></name><degrees>DPhil</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Deshpande</surname><given-names>Aniruddha</given-names></name><degrees>MPH</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Letourneau</surname><given-names>Ian</given-names></name><degrees>BA</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Morozoff</surname><given-names>Chloe</given-names></name><degrees>MPH</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Reiner</surname><given-names>Robert C</given-names><suffix>Jr</suffix></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Kraemer</surname><given-names>Moritz U G</given-names></name><degrees>DPhil</degrees><xref rid="aff2" ref-type="aff">b</xref><xref rid="aff7" ref-type="aff">g</xref><xref rid="aff8" ref-type="aff">h</xref></contrib><contrib contrib-type="author"><name><surname>Brent</surname><given-names>Shannon E</given-names></name><degrees>MPH</degrees><xref rid="aff9" ref-type="aff">i</xref></contrib><contrib contrib-type="author"><name><surname>Bogoch</surname><given-names>Isaac I</given-names></name><degrees>MD</degrees><xref rid="aff10" ref-type="aff">j</xref><xref rid="aff11" ref-type="aff">k</xref></contrib><contrib contrib-type="author"><name><surname>Khan</surname><given-names>Kamran</given-names></name><degrees>MD</degrees><xref rid="aff9" ref-type="aff">i</xref></contrib><contrib contrib-type="author"><name><surname>Biehl</surname><given-names>Molly H</given-names></name><degrees>MPH</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Burstein</surname><given-names>Roy</given-names></name><degrees>BA</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Earl</surname><given-names>Lucas</given-names></name><degrees>MSc</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Fullman</surname><given-names>Nancy</given-names></name><degrees>MPH</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Messina</surname><given-names>Jane P</given-names></name><degrees>PhD</degrees><xref rid="aff3" ref-type="aff">c</xref><xref rid="aff4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name><surname>Mylne</surname><given-names>Adrian Q N</given-names></name><degrees>MSc</degrees><xref rid="aff12" ref-type="aff">l</xref></contrib><contrib contrib-type="author"><name><surname>Moyes</surname><given-names>Catherine L</given-names></name><degrees>PhD</degrees><xref rid="aff5" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name><surname>Shearer</surname><given-names>Freya M</given-names></name><degrees>BSc</degrees><xref rid="aff5" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name><surname>Bhatt</surname><given-names>Samir</given-names></name><degrees>DPhil</degrees><xref rid="aff13" ref-type="aff">m</xref></contrib><contrib contrib-type="author"><name><surname>Brady</surname><given-names>Oliver J</given-names></name><degrees>DPhil</degrees><xref rid="aff14" ref-type="aff">n</xref></contrib><contrib contrib-type="author"><name><surname>Gething</surname><given-names>Peter W</given-names></name><degrees>PhD</degrees><xref rid="aff5" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name><surname>Weiss</surname><given-names>Daniel J</given-names></name><degrees>PhD</degrees><xref rid="aff5" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name><surname>Tatem</surname><given-names>Andrew J</given-names></name><degrees>PhD</degrees><xref rid="aff16" ref-type="aff">p</xref><xref rid="aff17" ref-type="aff">q</xref></contrib><contrib contrib-type="author"><name><surname>Caley</surname><given-names>Luke</given-names></name><degrees>MSc</degrees><xref rid="aff18" ref-type="aff">r</xref></contrib><contrib contrib-type="author"><name><surname>De Groeve</surname><given-names>Tom</given-names></name><degrees>PhD</degrees><xref rid="aff19" ref-type="aff">s</xref></contrib><contrib contrib-type="author"><name><surname>Vernaccini</surname><given-names>Luca</given-names></name><degrees>MSc</degrees><xref rid="aff19" ref-type="aff">s</xref></contrib><contrib contrib-type="author"><name><surname>Golding</surname><given-names>Nick</given-names></name><degrees>DPhil</degrees><xref rid="aff20" ref-type="aff">t</xref></contrib><contrib contrib-type="author"><name><surname>Horby</surname><given-names>Peter</given-names></name><degrees>Prof</degrees><degrees>PhD</degrees><xref rid="aff6" ref-type="aff">f</xref></contrib><contrib contrib-type="author"><name><surname>Kuhn</surname><given-names>Jens H</given-names></name><degrees>MD</degrees><xref rid="aff21" ref-type="aff">u</xref></contrib><contrib contrib-type="author"><name><surname>Laney</surname><given-names>Sandra J</given-names></name><degrees>PhD</degrees><xref rid="aff22" ref-type="aff">v</xref></contrib><contrib contrib-type="author"><name><surname>Ng</surname><given-names>Edmond</given-names></name><degrees>MSc</degrees><xref rid="aff15" ref-type="aff">o</xref></contrib><contrib contrib-type="author"><name><surname>Piot</surname><given-names>Peter</given-names></name><degrees>Prof</degrees><degrees>PhD</degrees><xref rid="aff15" ref-type="aff">o</xref></contrib><contrib contrib-type="author"><name><surname>Sankoh</surname><given-names>Osman</given-names></name><degrees>Prof</degrees><degrees>DSc</degrees><xref rid="aff23" ref-type="aff">w</xref></contrib><contrib contrib-type="author"><name><surname>Murray</surname><given-names>Christopher J L</given-names></name><degrees>Prof</degrees><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Hay</surname><given-names>Simon I</given-names></name><degrees>Prof</degrees><degrees>DSc</degrees><email>sihay@uw.edu</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff5" ref-type="aff">e</xref><xref rid="cor1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff1"><label>a</label>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA</aff><aff id="aff2"><label>b</label>Department of Zoology, University of Oxford, Oxford, UK</aff><aff id="aff3"><label>c</label>School of Geography and the Environment, University of Oxford, Oxford, UK</aff><aff id="aff4"><label>d</label>School of Interdisciplinary Area Studies, University of Oxford, Oxford, UK</aff><aff id="aff5"><label>e</label>Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK</aff><aff id="aff6"><label>f</label>Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK</aff><aff id="aff7"><label>g</label>Harvard Medical School, Harvard University, Boston, MA, USA</aff><aff id="aff8"><label>h</label>Boston Children's Hospital, Boston, MA, USA</aff><aff id="aff9"><label>i</label>Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada</aff><aff id="aff10"><label>j</label>Divisions of General Internal Medicine and Infectious Diseases, Toronto General Hospital, Toronto, ON, Canada</aff><aff id="aff11"><label>k</label>Department of Medicine, University of Toronto, Toronto, ON, Canada</aff><aff id="aff12"><label>l</label>Warwick Medical School, University of Warwick, Coventry, UK</aff><aff id="aff13"><label>m</label>Department of Infectious Disease Epidemiology, Imperial College London, London, UK</aff><aff id="aff14"><label>n</label>Department of Infectious Disease Epidemiology, London School of Hygiene &#x00026; Tropical Medicine, London, UK</aff><aff id="aff15"><label>o</label>Director's Office, London School of Hygiene &#x00026; Tropical Medicine, London, UK</aff><aff id="aff16"><label>p</label>WorldPop, Department of Geography and Environment, University of Southampton, Southampton, UK</aff><aff id="aff17"><label>q</label>Flowminder Foundation, Stockholm Sweden</aff><aff id="aff18"><label>r</label>The Start Network, London, UK</aff><aff id="aff19"><label>s</label>European Commission, Joint Research Centre, Ispra, Italy</aff><aff id="aff20"><label>t</label>Quantitative and Applied Ecology Group, School of BioSciences, University of Melbourne, Parkville, VIC, Australia</aff><aff id="aff21"><label>u</label>Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA</aff><aff id="aff22"><label>v</label>SJL Global Consulting, Seattle, WA, USA</aff><aff id="aff23"><label>w</label>INDEPTH Network, Accra, Ghana</aff><author-notes><corresp id="cor1"><label>*</label>Correspondence to: Prof Simon I Hay, Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA 98121, USACorrespondence to: Prof Simon I Hay, Institute for Health Metrics and EvaluationUniversity of WashingtonSeattleWA98121USA <email>sihay@uw.edu</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>16</day><month>12</month><year>2017</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.--><pub-date pub-type="ppub"><day>16</day><month>12</month><year>2017</year></pub-date><volume>390</volume><issue>10113</issue><fpage>2662</fpage><lpage>2672</lpage><permissions><copyright-statement>&#x000a9; 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license</copyright-statement><copyright-year>2017</copyright-year><license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><related-article related-article-type="article-reference" id="d31e12" ext-link-type="doi" xlink:href="10.1016/S0140-6736(17)32475-3"/><abstract id="ceab10"><title>Summary</title><sec><title>Background</title><p>Predicting when and where pathogens will emerge is difficult, yet, as shown by the recent Ebola and Zika epidemics, effective and timely responses are key. It is therefore crucial to transition from reactive to proactive responses for these pathogens. To better identify priorities for outbreak mitigation and prevention, we developed a cohesive framework combining disparate methods and data sources, and assessed subnational pandemic potential for four viral haemorrhagic fevers in Africa, Crimean&#x02013;Congo haemorrhagic fever, Ebola virus disease, Lassa fever, and Marburg virus disease.</p></sec><sec><title>Methods</title><p>In this multistage analysis, we quantified three stages underlying the potential of widespread viral haemorrhagic fever epidemics. Environmental suitability maps were used to define stage 1, index-case potential, which assesses populations at risk of infection due to spillover from zoonotic hosts or vectors, identifying where index cases could present. Stage 2, outbreak potential, iterates upon an existing framework, the Index for Risk Management, to measure potential for secondary spread in people within specific communities. For stage 3, epidemic potential, we combined local and international scale connectivity assessments with stage 2 to evaluate possible spread of local outbreaks nationally, regionally, and internationally.</p></sec><sec><title>Findings</title><p>We found epidemic potential to vary within Africa, with regions where viral haemorrhagic fever outbreaks have previously occurred (eg, western Africa) and areas currently considered non-endemic (eg, Cameroon and Ethiopia) both ranking highly. Tracking transitions between stages showed how an index case can escalate into a widespread epidemic in the absence of intervention (eg, Nigeria and Guinea). Our analysis showed Chad, Somalia, and South Sudan to be highly susceptible to any outbreak at subnational levels.</p></sec><sec><title>Interpretation</title><p>Our analysis provides a unified assessment of potential epidemic trajectories, with the aim of allowing national and international agencies to pre-emptively evaluate needs and target resources. Within each country, our framework identifies at-risk subnational locations in which to improve surveillance, diagnostic capabilities, and health systems in parallel with the design of policies for optimal responses at each stage. In conjunction with pandemic preparedness activities, assessments such as ours can identify regions where needs and provisions do not align, and thus should be targeted for future strengthening and support.</p></sec><sec><title>Funding</title><p>Paul G Allen Family Foundation, Bill &#x00026; Melinda Gates Foundation, Wellcome Trust, UK Department for International Development.</p></sec></abstract></article-meta></front><body><sec id="cesec10"><title>Introduction</title><p id="para10">The Ebola virus disease outbreak, which centred in Guinea, Liberia, and Sierra Leone, was unprecedented both in terms of mortality and morbidity, as well as the extent to which the disease spread locally and internationally.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> The unanticipated cases of Ebola virus disease in regions previously considered non-endemic, coupled with inadequate infrastructure and susceptible, yet highly mobile populations, might have contributed to the outbreak infecting over 60 times more individuals than any previous Ebola virus disease outbreak.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> As pathogens continue to emerge and spread into populations at-risk, a move from purely responsive activities to also include proactive management of emerging infectious diseases is urgently needed.<xref rid="bib3" ref-type="bibr">3</xref>, <xref rid="bib4" ref-type="bibr">4</xref> The current paradigm of responding to these threats as and when they arise is expensive and unsustainable.<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> Initiatives such as the Coalition for Epidemic Preparedness Innovations and the US Global Health Security Agenda, with its renewed focus on achieving the International Health Regulations, have reinforced a need for a proactive approach to emerging infectious diseases.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> Consequently, there is great interest in the development of tools to help pre-empt such outbreaks and inform broad-scale health-system strengthening with respect to emerging infectious diseases,<xref rid="bib7" ref-type="bibr">7</xref>, <xref rid="bib8" ref-type="bibr">8</xref> and particularly, to establish the prioritisation of limited resources<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref> and the optimal deployment of surveillance, preventive measures, and treatments.</p><p id="para20"><boxed-text id="cetextbox10"><caption><title>Research in context</title></caption><p id="para30"><bold>Evidence before this study</bold></p><p id="para40">We searched PubMed with search terms &#x0201c;viral haemorrhagic fever preparedness&#x0201d;, &#x0201c;viral haemorrhagic fever risk assessment&#x0201d;, &#x0201c;pandemic risk assessment&#x0201d;, and &#x0201c;pandemic preparedness&#x0201d;, for articles published between Jan 1, 1990, and July 1, 2016, with supplemental searches in Google Scholar. Articles assessing subnational variation in pandemic risk or evaluating this risk across broad geographic scales were included. A variety of analytical approaches have been developed to assess different aspects of outbreak risk, including environmental correlates to define regions of possible pathogen emergence, models of population connectivity to determine potential spread, and analyses of drivers of incidence and prevalence at local and national levels. Most of these assessments are retrospective, or delayed due to time lags in data availability and hence may have limited utility for improving epidemic preparedness. Pre-emptive assessments of epidemics, leveraging common features from such work are less common. Hotspots of disease emergence have been identified and indices developed to gauge national-level susceptibility to infectious pathogens, representing important first steps in assessing risk. To date, however, no analyses have quantified how these vulnerabilities might change during different stages of an outbreak, nor have they consistently evaluated such vulnerabilities for the spatial granularity at which outbreaks occur and are addressed.</p><p id="para50"><bold>Added value of this study</bold></p><p id="para60">This study builds upon previous preparedness concepts to develop a subnational evaluation of epidemic potential across Africa. For the first time, within a single pandemic potential framework, our analyses show how different stages of an outbreak can be quantified and evaluated before the next outbreak. We use a new combination of methods to provide a complete picture of potential outbreak progression, from initial spillover resulting in an index case to broader regional and international spread; thus allowing countries to directly focus on places where disease emergence and subsequent transmission could have the greatest impact on human health.</p><p id="para70"><bold>Implications of all the available evidence</bold></p><p id="para80">Our results allow both governmental and non-governmental organisations to better understand epidemic potential, and offer pre-emptive planning to address vulnerabilities before the next outbreak of viral haemorrhagic fever. Using these results in tandem with existing in-country evaluations, such as the Joint External Evaluations, allows stakeholders to establish whether outbreak preparedness activities, broader governmental initiatives, or pathogen-specific control measures, are being targeted appropriately to places with future outbreak potential. Regions where there is a mismatch between pandemic potential and existing preparedness activities should therefore be considered as priorities in future preparedness planning. By moving preparedness discussions from national to subnational assessments, outbreak response protocols can better reflect the demands that epidemics present to local health systems.</p></boxed-text></p><p id="para90">Several studies have identified pathogens with pandemic potential and key drivers of their distribution and emergence,<xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib11" ref-type="bibr">11</xref> as well as defined vulnerable countries.<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> Further, various methods and technologies can be used once cases are reported, aiding the response, tracking, and predicting progression from an index case to widespread epidemic.<xref rid="bib13" ref-type="bibr">13</xref>, <xref rid="bib14" ref-type="bibr">14</xref>, <xref rid="bib15" ref-type="bibr">15</xref>, <xref rid="bib16" ref-type="bibr">16</xref> However, few systems are in place to synthesise these disparate analyses in a consolidated framework that outlines this potential progression,<xref rid="bib17" ref-type="bibr">17</xref>, <xref rid="bib18" ref-type="bibr">18</xref> and no work to date, to our knowledge, accounts for subnational variations that more closely reflect the geographic level at which outbreaks occur.</p><p id="para100">Viral haemorrhagic fevers, such as Crimean&#x02013;Congo haemorrhagic fever, Ebola virus disease, Lassa fever, and Marburg virus disease, are present in Africa and have the potential for secondary human-to-human transmission after zoonotic spillover into human populations, with initial clinical presentation similar to several other pathogens. Subsequently, they pose a risk to populations in both endemic and non-endemic locations, particularly where rapid diagnostic capacity is low.<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref></p><p id="para110">To assess the ability of these pathogens to cause a widespread epidemic, we developed a framework that focuses on key transition points in a potential outbreak. By addressing different stages of an epidemic, we aim to provide actionable information on where to focus existing countermeasures. Additionally, by using a subnational unit of reference, we aim to provide information at a scale comparable to the localised nature of outbreaks, allowing for identification of communities at greatest risk. Drawing from multiple data sources and methods, this study outlines a three-stage framework (<xref rid="fig1" ref-type="fig">figure 1</xref>): stage 1, index-case potential, describes the transition (spillover) from zoonotic reservoirs or vectors into human populations, resulting in an index case (ie, the first case in any potential epidemic); stage 2, outbreak potential, characterises the subsequent secondary spread of the pathogen in people, typically localised where care is given, whether at home or in the health-care system and nearby settlements; stage 3, epidemic potential, describes the processes by which local outbreaks can subsequently cause infections elsewhere nationally, regionally, and internationally.<fig id="fig1"><label>Figure 1</label><caption><p>Conceptual progression of a viral haemorrhagic fever from animal reservoir to global pandemic</p><p>Keys stages in the progression to a potential widespread epidemic are summarised. Stage 1, index-case potential, refers to spillover viral transmission from animal reservoir to index cases. Stage 2, outbreak potential, represents an index case infecting individuals within the local community or in a care-giving setting quantified via a composite indicator assessing outbreak receptivity. Stage 3, epidemic potential, re&#x0fb02;ects the widespread transmission of the virus both at regional and international scales.</p></caption><graphic xlink:href="gr1"/></fig></p></sec><sec id="cesec20"><title>Methods</title><sec id="cesec30"><title>Overview</title><p id="para120">In this multistage analysis, we characterised three stages of a potential viral haemorrhagic fever outbreak with a variety of methods and datasets (<xref rid="tbl1" ref-type="table">table</xref>). We used environmental suitability maps to define at-risk populations for stage 1. Stage 2 is an adaptation of an existing risk framework, the Index for Risk Management (INFORM),<xref rid="bib44" ref-type="bibr">44</xref>, <xref rid="bib45" ref-type="bibr">45</xref> and uses a composite indicator to assess variation in outbreak receptivity (ie, locations where continued transmission in people is more likely to occur) combined with stage 1 estimates to identify regions with the highest potential for localised outbreaks. For stage 3, we combine connectivity assessments, both at the local and international scale, with stage 2 to establish regions with the highest potential for widespread epidemics.<table-wrap id="tbl1" position="float"><label>Table</label><caption><p>Input datasets used in the pandemic potential framework</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th align="left"><bold>Resolution</bold></th><th align="left"><bold>Data source</bold></th></tr></thead><tbody><tr><td colspan="4" align="left"><bold>Stage 1 index case potential</bold></td></tr><tr><td colspan="2" align="left">Crimean&#x02013;Congo haemorrhagic fever: environmental suitability</td><td align="left">5&#x02008;&#x000d7;&#x02008;5 km</td><td align="left">Messina et al<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref></td></tr><tr><td colspan="2" align="left">Crimean&#x02013;Congo haemorrhagic fever: occurrence records</td><td align="left">Geopositioned records</td><td align="left">Messina et al<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref></td></tr><tr><td colspan="2" align="left">Ebola virus disease: environmental suitability</td><td align="left">5&#x02008;&#x000d7;&#x02008;5 km</td><td align="left">Pigott et al<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref></td></tr><tr><td colspan="2" align="left">Ebola virus disease: occurrence records</td><td align="left">Geopositioned records</td><td align="left">Mylne et al<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref></td></tr><tr><td colspan="2" align="left">Lassa fever: environmental suitability and occurrence records</td><td align="left">5&#x02008;&#x000d7;&#x02008;5 km</td><td align="left">Mylne et al<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref></td></tr><tr><td colspan="2" align="left">Marburg virus disease: environmental suitability and occurrence records</td><td align="left">5&#x02008;&#x000d7;&#x02008;5 km</td><td align="left">Pigott et al<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref></td></tr><tr><td colspan="2" align="left">Population</td><td align="left">5&#x02008;&#x000d7;&#x02008;5 km</td><td align="left">WorldPop<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref></td></tr><tr><td colspan="4" align="left"><bold>Stage 2 outbreak potential</bold></td></tr><tr><td colspan="4" align="left">Governance</td></tr><tr><td/><td align="left">Government effectiveness</td><td align="left">National</td><td align="left">World Bank<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref></td></tr><tr><td/><td align="left">Corruption perception index<xref rid="tbl1fn1" ref-type="table-fn">*</xref></td><td align="left">National</td><td align="left">Transparency International<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref></td></tr><tr><td/><td align="left">Donor aid</td><td align="left">National</td><td align="left">IHME<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref></td></tr><tr><td/><td align="left">Conflict</td><td align="left">Subnational</td><td align="left">ACLED<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref></td></tr><tr><td colspan="4" align="left">Communications</td></tr><tr><td/><td align="left">Educational attainment</td><td align="left">National</td><td align="left">IHME<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref></td></tr><tr><td/><td align="left">Internet</td><td align="left">National</td><td align="left">World Bank<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref></td></tr><tr><td/><td align="left">Cellular phone subscriptions</td><td align="left">National</td><td align="left">World Bank<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref></td></tr><tr><td/><td align="left">Electricity</td><td align="left">National</td><td align="left">World Bank<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref></td></tr><tr><td colspan="4" align="left">Isolation</td></tr><tr><td/><td align="left">Proportion rural</td><td align="left">5&#x02008;&#x000d7;&#x02008;5 km</td><td align="left">GRUMP<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref></td></tr><tr><td/><td align="left">Travel time to nearest major settlement</td><td align="left">5&#x02008;&#x000d7;&#x02008;5 km</td><td align="left">Nelson<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref></td></tr><tr><td colspan="4" align="left">Infrastructure</td></tr><tr><td/><td align="left">Access to improved water</td><td align="left">National and subnational</td><td align="left">GAHI<xref rid="bib37" ref-type="bibr"><sup>37</sup></xref> and IHME<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref></td></tr><tr><td/><td align="left">Access to improved sanitation</td><td align="left">National and subnational</td><td align="left">GAHI<xref rid="bib37" ref-type="bibr"><sup>37</sup></xref> and IHME<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref></td></tr><tr><td colspan="4" align="left">Health care</td></tr><tr><td/><td align="left">DPT3 coverage</td><td align="left">National</td><td align="left">WHO<xref rid="bib39" ref-type="bibr"><sup>39</sup></xref></td></tr><tr><td/><td align="left">Lower respiratory infections<xref rid="tbl1fn1" ref-type="table-fn">*</xref></td><td align="left">National</td><td align="left">IHME<xref rid="bib40" ref-type="bibr">40</xref>, <xref rid="bib41" ref-type="bibr">41</xref></td></tr><tr><td/><td align="left">Diarrhoeal disease<xref rid="tbl1fn1" ref-type="table-fn">*</xref></td><td align="left">National</td><td align="left">IHME<xref rid="bib40" ref-type="bibr">40</xref>, <xref rid="bib41" ref-type="bibr">41</xref></td></tr><tr><td/><td align="left">Health-care expenditure as a percentage of GDP</td><td align="left">National</td><td align="left">WHO<xref rid="bib42" ref-type="bibr"><sup>42</sup></xref></td></tr><tr><td/><td align="left">Under-5 mortality</td><td align="left">5&#x02008;&#x000d7;&#x02008;5 km</td><td align="left">Golding et al<xref rid="bib43" ref-type="bibr"><sup>43</sup></xref></td></tr><tr><td colspan="4" align="left"><bold>Stage 3 epidemic potential</bold></td></tr><tr><td colspan="2" align="left">Travel time to nearest major settlement</td><td align="left">5&#x02008;&#x000d7;&#x02008;5 km</td><td align="left">Nelson<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref></td></tr><tr><td colspan="2" align="left">Outbound passenger volume (flights)</td><td align="left">National</td><td align="left">IATA<xref rid="tbl1fn2" ref-type="table-fn">&#x02020;</xref></td></tr></tbody></table><table-wrap-foot><fn><p>The table outlines covariates included for each stage, and their provenance. In stage 2, each component is broken down into its constituent factors: governance, communications, isolation, infrastructure, and health care. IHME=Institute for Health Metrics and Evaluation. ACLED=Armed Conflict Location &#x00026; Event Data Project. GAHI=Global Alliance for Humanitarian Innovation. GRUMP=Global Rural-Urban Mapping Project. DPT3=diphtheria-tetanus-pertussis. GDP=gross domestic product. IATA=International Air Transport Association.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl1fn1"><label>*</label><p id="cenpara10">Excluded after redundancy analysis.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl1fn2"><label>&#x02020;</label><p id="cenpara20">Data not publicly available.</p></fn></table-wrap-foot></table-wrap></p><p id="para130">We assessed information at the second national administrative division (admin 2) as defined by the UN Food and Agriculture Organization.<xref rid="bib46" ref-type="bibr"><sup>46</sup></xref> Following INFORM protocols, we normalised covariate factors and standardised to a 0&#x02013;10 output, with 10 representing the worst outcome. Contingent on the potential for compensatory effects between factors, we used either geometric or arithmetic means when aggregating data, with each stage building on the previous stage. We established uncertainty by calculating 1000 draws, each using independent random draws for covariates with associated variance. We assessed uncertainty at each of the three stages. Aggregation of the results for all stages occurs after this process, ensuring a full record of the uncertainty by stage. Importantly, the output measures of median ranks allow for comparison, but are not direct representations of quantitative differences in potential case numbers and deaths.</p><p id="para140">This study follows the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER).<xref rid="bib47" ref-type="bibr"><sup>47</sup></xref> Further details on the estimation and data sources used in this analysis are included in the <ext-link ext-link-type="uri" xlink:href="http://ghdx.healthdata.org/" id="interrefs20">supplementary materials</ext-link>, and all code used for these analyses are available on request from the corresponding author.</p></sec><sec id="cesec40"><title>Stage 1: assessing index-case potential based on environmental suitability</title><p id="para150">We used existing models of environmental suitability for the transmission of a virus from environmental sources into human populations to establish regions at risk of spillover infections.<xref rid="bib20" ref-type="bibr">20</xref>, <xref rid="bib22" ref-type="bibr">22</xref>, <xref rid="bib24" ref-type="bibr">24</xref>, <xref rid="bib25" ref-type="bibr">25</xref>, <xref rid="bib48" ref-type="bibr">48</xref> These maps use reported geographic information on index cases of outbreaks and viral detection in animals,<xref rid="bib21" ref-type="bibr">21</xref>, <xref rid="bib23" ref-type="bibr">23</xref>, <xref rid="bib24" ref-type="bibr">24</xref>, <xref rid="bib25" ref-type="bibr">25</xref> which are related to environmental drivers using species distribution models.<xref rid="bib49" ref-type="bibr">49</xref>, <xref rid="bib50" ref-type="bibr">50</xref> We compiled this information to build an environmental profile that best characterises possible pathogen presence. Subsequently, areas of unknown disease status can be evaluated based on their environmental profile similarities. We calculated a data-driven threshold value defining at-risk areas by assessing different groupings of reported disease occurrences and background records, and the ability of each threshold to accurately classify them.<xref rid="bib51" ref-type="bibr">51</xref>, <xref rid="bib52" ref-type="bibr">52</xref> This process was repeated 1000 times. Total population count evaluated at a 5&#x02008;&#x000d7;&#x02008;5 km resolution,<xref rid="bib53" ref-type="bibr"><sup>53</sup></xref> and the proportion of the total administrative unit population living within these locations, were aggregated to the admin 2 level<xref rid="bib46" ref-type="bibr"><sup>46</sup></xref> and standardised on a scale of 0&#x02013;10.<xref rid="bib44" ref-type="bibr"><sup>44</sup></xref> We evaluated a final stage 1 value by calculating an inverted geometric mean of these two population measures.<xref rid="bib44" ref-type="bibr"><sup>44</sup></xref> More detail on the conversion of these niche maps and quantification of populations at risk is provided in the supplementary materials.</p></sec><sec id="cesec50"><title>Stage 2: quantifying outbreak potential</title><p id="para160">We paired stage 1 estimates of index-case potential with a composite indicator of measures termed outbreak receptivity (<xref rid="tbl1" ref-type="table">table</xref>) to produce admin 2 level outbreak potential assessments, identifying locations more likely to experience secondary human-to-human viral transmission. We established an initial set of measures, referred to here as factors, through expert consultation based on the INFORM study,<xref rid="bib44" ref-type="bibr"><sup>44</sup></xref> and revised for relevance to infectious diseases through a meeting at UK Department for International Development. We identified factors and grouped them into five key components: governance,<xref rid="bib27" ref-type="bibr">27</xref>, <xref rid="bib28" ref-type="bibr">28</xref>, <xref rid="bib29" ref-type="bibr">29</xref>, <xref rid="bib54" ref-type="bibr">54</xref> communications,<xref rid="bib31" ref-type="bibr">31</xref>, <xref rid="bib32" ref-type="bibr">32</xref>, <xref rid="bib33" ref-type="bibr">33</xref>, <xref rid="bib34" ref-type="bibr">34</xref> isolation,<xref rid="bib35" ref-type="bibr">35</xref>, <xref rid="bib36" ref-type="bibr">36</xref> infrastructure,<xref rid="bib37" ref-type="bibr">37</xref>, <xref rid="bib38" ref-type="bibr">38</xref> and health care,<xref rid="bib39" ref-type="bibr">39</xref>, <xref rid="bib40" ref-type="bibr">40</xref>, <xref rid="bib41" ref-type="bibr">41</xref>, <xref rid="bib42" ref-type="bibr">42</xref>, <xref rid="bib43" ref-type="bibr">43</xref> based on hypothesised similar effects on outbreaks. This outbreak receptivity indicator and its components are intended to reflect the susceptibility of a given location to continued transmission based on the resident population and existing response infrastructure. Thus, each included factor is a hypothesised correlate of continued secondary transmission.</p><p id="para170">Other factors such as access to personal protective equipment or number of isolation wards were considered, but were ultimately excluded because data at a continental scale were not available. We collected information on each factor at the highest possible spatial resolution and summarised data at the admin 2 level. We standardised inputs to a 0&#x02013;10 scale, including normalisation where appropriate, using optimised Box-Cox transformations,<xref rid="bib55" ref-type="bibr"><sup>55</sup></xref> and input variation simulated by drawing values from uncertainty estimates or data time series (supplementary materials). We took 1000 draws for each admin 2 per factor and aggregated into respective components, and then the composite indicator (<xref rid="tbl1" ref-type="table">table</xref>). Initial aggregation weighed components equally. In testing this composite indicator, we identified uniqueness among factors via principal components analysis, and removed redundant factors (ie, those with similar scores across the first two principal components).<xref rid="bib44" ref-type="bibr"><sup>44</sup></xref> We calculated variance-based importance metrics for sensitivity to analyse unintentional dominance of any one component.<xref rid="bib56" ref-type="bibr">56</xref>, <xref rid="bib57" ref-type="bibr">57</xref> Given that a subset of all possible outbreak drivers are used with no a priori rationale for one component being dominant, we enforced equivalence by reweighting the arithmetic mean so that the differences in variance explained of the final composite indicator by each component were reduced. We coupled the resultant outbreak receptivity values with stage 1 outputs for each pathogen by taking their geometric mean, to produce the final stage 2 evaluation.</p></sec><sec id="cesec60"><title>Stage 3: estimating epidemic potential based on local and international connectivity</title><p id="para180">We evaluated two dimensions of epidemic potential for stage 3. First, we assessed the source capacity of an admin 2 unit (ie, the potential for an outbreak to seed infections in other locations) (stage 3a) by measuring the average travel time from a given 5&#x02008;&#x000d7;&#x02008;5 km unit in each admin 2 to the nearest city (defined as over 50&#x02008;000 inhabitants).<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref> With this calculation, we identified the at-risk locations most likely to be exporters of infected individuals, in the absence of barriers to movement such as border restrictions. The travel time covariate uses information on land cover and existing infrastructure to estimate the shortest travel time from any given point to nearby settlements. We normalised this covariate and standardised to a 0&#x02013;10 scale, and the geometric mean of stage 2 outputs and this covariate were taken to produce the measure for stage 3a. Second, we assessed international source capacity (stage 3b) with anonymised passenger-level flight itineraries from the International Air Transport Association for 2015, which included details on passengers' initial airport of embarkation and final destination.<xref rid="bib14" ref-type="bibr">14</xref>, <xref rid="bib58" ref-type="bibr">58</xref> We produced the estimate for epidemic potential by pairing national patterns of outbound passenger volume to any other global destination, with stage 2 outputs using geometric means.</p></sec><sec id="cesec70"><title>Role of the funding source</title><p id="para190">The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.</p></sec></sec><sec id="cesec80"><title>Results</title><p id="para200">Here, we provide estimates for each at-risk subnational admin 2 in Africa across the three stages of a potential outbreak (<xref rid="fig2" ref-type="fig">figure 2</xref>). Interactive maps are made available via <ext-link ext-link-type="uri" xlink:href="https://vizhub.healthdata.org/geospatial/pandemics" id="interrefs30">online visualisation tools</ext-link>.<fig id="fig2"><label>Figure 2</label><caption><p>Pandemic potential of four African viral haemorrhagic fevers</p><p>Each column represents the various stages of a potential pandemic, from initial index-case potential (first row) and outbreak potential (second row) to local epidemic potential (third row) and global epidemic potential (fourth row). Columns, moving from left to right, show this progression for Crimean&#x02013;Congo haemorrhagic fever, Ebola virus disease, Lassa fever, and Marburg virus disease. For each figure, administrative units coloured in red are those with median values (based on 1000 draws) that rank in the top quintile of ranked units; units in dark green have median values that rank in the lowest quintile. Interactive maps are available via the <ext-link ext-link-type="uri" xlink:href="https://vizhub.healthdata.org/geospatial/pandemics" id="interrefs10">online visualisation tools</ext-link>.</p></caption><graphic xlink:href="gr2"/></fig></p><p id="para210">Across Africa, the ranking of subnational regions in stage 1, identification of locations with the greatest potential for index cases, reflected key trends observed in the original zoonotic niche maps (<xref rid="fig2" ref-type="fig">figure 2, first row</xref>). All admin 2 areas are ordered so that regions with the highest index-case potential are highest ranked. Areas susceptible to spillover of Crimean&#x02013;Congo haemorrhagic fever were widespread, with the highest ranked admin 2 units found in the Sahel (eg, Kollo, Niger), the Horn of Africa (eg, Sennar, Sudan), and southern Africa (eg, Johannesburg, South Africa). By contrast, Lassa fever was restricted to areas in western Africa such as in Guinea (eg, Gu&#x000e9;ck&#x000e9;dou) and Nigeria (eg, Ife North), whereas Ebola virus disease had highest ranked admin 2 units, and thus those with the highest potential for index cases, found in both western Africa (eg, Macenta, Guinea and Foya, Liberia) and middle Africa (eg, Woleu, Gabon and Haut-Uele, the Democratic Republic of the Congo). Highest ranked locations for Marburg virus disease were present across the continent (eg, Mwenge, Uganda; Voinjama, Liberia; and Beni, the Democratic Republic of the Congo). Although many regions in the highest quintile were located in countries with previous outbreaks, several locations with no previous outbreaks had high index-case potential, such as Boumba-et-Ngoko in Cameroon for Ebola virus disease (<xref rid="fig3" ref-type="fig">figure 3</xref>).<fig id="fig3"><label>Figure 3</label><caption><p>Index-case potential across countries that did not previously report spillover events</p><p>Stage 1 index-case potential masked by previous reporting of index cases for Crimean&#x02013;Congo haemorrhagic fever (A), Ebola virus disease (B), Lassa fever (C), and Marburg virus disease (D). Countries in dark grey are those that have previously seen spillover index cases reported. The remaining at-risk administrative units coloured in red are those with median values (based on 1000 draws) that rank in the top quintile of ranked remaining units; those coloured in green have median values that rank in the lowest quintile.</p></caption><graphic xlink:href="gr3"/></fig></p><p id="para220">Outbreak receptivity, the composite indicator used in stage 2 to identify regions susceptible to ongoing secondary transmission, revealed substantial variation in capabilities to effectively respond to index cases (<xref rid="fig4" ref-type="fig">figure 4</xref>). At least 90% of the districts found in the Central African Republic, Chad, Somalia, and South Sudan ranked in the top 90th percentile of African locations, or in other words, those administrative units with the most susceptible populations and poorest response capacity. More than 80% of admin 2 units in Guinea, Madagascar, and Sudan were in the top 70th percentile or higher for outbreak receptivity.<fig id="fig4"><label>Figure 4</label><caption><p>Outbreak receptivity</p><p>The map displays the final outbreak receptivity indicator, a component in the stage 2 evaluation. Administrative units coloured in red are those with median values (based on 1000 draws) that rank in the top quintile of ranked units; those in dark blue have median values that rank in the lowest quintile. Interactive maps are available via the online visualisation tools.</p></caption><graphic xlink:href="gr4"/></fig></p><p id="para230">Pairing outbreak receptivity (stage 2) with index-case potential (stage 1) highlights key differences in pathogen-specific vulnerabilities between locations (<xref rid="fig2" ref-type="fig">figure 2</xref>, second row) which shows that some regions are more susceptible to continued human-to-human transmission. Locations rising up the rankings between stages indicate that, in the event of an index case, these would be key targets for rapid and effective intervention, to avert local outbreaks. For Crimean&#x02013;Congo haemorrhagic fever, many at-risk districts increased in rankings, particularly in Somalia (54% increase in districts in top quintile admin 2) and across the Sahel, such as within Sudan (+25%) and Niger (+14%). Conversely, rankings decreased between stages in all districts in South Africa (85% reduction in top quintile admin 2) as well as parts of Kenya (&#x02212;51%) and Tanzania (&#x02212;29%). Similar patterns were observed with Ebola virus disease, with locations in Angola (+14%), the Central African Republic (+7%), and South Sudan (+7%) ranking higher, whereas districts in C&#x000f4;te d'Ivoire (&#x02212;5%) and Uganda (&#x02212;19%) decreased between stages. By contrast with Ebola virus disease, Lassa fever showed variable changes in ranking across western Africa; Guinean districts rose in ranking (+15%), Ivorian districts decreased (&#x02212;28%), and Nigerian districts reflected the heterogeneities in receptivity found across the country. For Marburg virus disease, rankings rose most in at-risk districts in Angola (+13%) and the Democratic Republic of the Congo (+21%), whereas similar national-level trends occurred in line with changes seen in Ebola virus disease rankings (eg, 35% reduction in top quintile admin 2 units in Uganda).</p><p id="para240">Travel time to nearest city in stage 3a revealed large variations in connectivity across Africa, contrasting the densely populated and urbanised regions in northern and western Africa with the Sahara and the rainforests of middle Africa. For instance, the isolation of forested areas in middle Africa contributed to substantial reductions in rankings (<xref rid="fig2" ref-type="fig">figure 2</xref>, third row, stage 3a), and suggest lower potential for a widespread outbreak of Crimean&#x02013;Congo haemorrhagic fever, Ebola virus disease, or Marburg virus disease occurring in Congo (14% and 15% reduction in top quintile admin 2 for Ebola virus disease and Marburg virus disease), the Democratic Republic of the Congo (&#x02212;43% Crimean&#x02013;Congo haemorrhagic fever, &#x02212;21% Ebola virus disease, &#x02212;18% Marburg virus disease), and Gabon (&#x02212;40% Ebola virus disease, &#x02212;29% Marburg virus disease). Conversely, much of western Africa rose in the ranking for epidemic potential, particularly in Nigeria (+20% Crimean&#x02013;Congo haemorrhagic fever, +29% Ebola virus disease, and +19% Marburg virus disease), Guinea (+28% Ebola virus disease, +27% Marburg virus disease), and Sierra Leone (+25% Ebola virus disease). A similar trend was seen for densely populated regions of eastern Africa, such as Uganda (+19% Ebola virus disease, +23% Marburg virus disease), indicating that these locations have a greater potential to spread to neighbouring areas. To that end, comparison of local outbreak potential with international spread capability also highlights important trends (<xref rid="fig2" ref-type="fig">figure 2</xref>, fourth row, stage 3b). For Crimean&#x02013;Congo haemorrhagic fever, with only low rankings in receptivity, the potential for international spread was high for South Africa (81% increase in top quintile admin 2) and at-risk districts in Nigeria represented many of those with the highest potential for global spread (+30% Crimean&#x02013;Congo haemorrhagic fever, +59% Ebola virus disease, +42% Marburg virus disease, +18% Lassa fever).</p></sec><sec id="cesec90"><title>Discussion</title><p id="para250">We report large heterogeneities across Africa in potential for zoonotic spillover resulting in index cases and their subsequent potential to result in local outbreaks or spread to neighbouring districts or countries. Several locations rank highly for localised outbreaks, but are comparatively less likely to spread elsewhere due to their isolation (eg, forests in middle Africa). Other locations, many in western Africa, rank highly both in terms of viral haemorrhagic fever outbreak potential and capacity to spread in the absence of effective interventions. Identification of regions with the greatest increases in rank between stages highlights key transition points in which interventions are crucial for preventing epidemics.</p><p id="para260">We hope this work can inform investments at each stage of potential epidemic progression: identification of regions requiring heightened surveillance in people and animals (stage 1) such as bat surveillance in Cameroon;<xref rid="bib59" ref-type="bibr"><sup>59</sup></xref> strengthening of core pandemic preparedness and response capacities (stage 2) by addressing weaknesses in health provisioning in Chad, Somalia, and South Sudan; and pre-emptive identification of places that are likely to be key distributors in any potential outbreak (stage 3) such as highly connected Nigerian and Ugandan admin 2 units. For stage 1, this assessment highlights the subnational variation that exists in at-risk populations, providing additional evidence concerning spillover potential in places that are considered non-endemic, such as Ebola virus disease in the Central African Republic. Proactive surveillance in animal populations can help these locations better evaluate emerging infectious disease threats. Additionally, highest ranked locations should be provisioned with the necessary diagnostic capacity to ensure timely and accurate diagnosis.</p><p id="para270">Stage 2, quantifying outbreak potential, provides a data-informed framework for targeting where to focus resources for health-system strengthening. Coupling these with Joint External Evaluations to establish where there are unmet needs in outbreak response will identify key priorities for future investment. Ensuring health-care workers are aware of possible index-case presentation is an important first step in minimising the potential for nosocomial secondary spread.<xref rid="bib60" ref-type="bibr"><sup>60</sup></xref> With candidate vaccines in development, these assessments can also inform where stockpiles might be most appropriate.<xref rid="bib61" ref-type="bibr"><sup>61</sup></xref> Finally, stage 3, assessing the potential for further geographic spread, allows for an in-depth examination of where high connectivity could result in widespread infection and how to design interventions, such as ring vaccination,<xref rid="bib62" ref-type="bibr"><sup>62</sup></xref> to halt continued transmission. Overlaying highly ranked locations identifies where these efforts could be most effective across a variety of scenarios (supplementary materials).</p><p id="para280">This framework is not dependent on there being an outbreak and can therefore support the proactive development of national and regional contingency plans by ministries of health and non-governmental organisations. Where vulnerabilities are identified, communities can appropriately prepare and rectify issues in advance. Understanding where potential outbreaks might occur and prospective transmission trajectories is an important step in establishing informed protocols for prevention and control. Indeed, even when cases occur, this framework combined with specific modelling strategies by stage and pathogen can inform focal control and response efforts. Aligning future priority pathogens with strategic investment in vaccine countermeasures targets (eg, Nipah virus) or other organisations' aims, will maximise the value of these outputs.</p><p id="para290">It is important to consider the limitations of this approach. The geographic scope of currently measured factors and the need for their completeness necessitates the use of proxy covariate factors rather than specific drivers. Assuming that spillover potential scales with population, rather than explicit assessment of human-animal interactions, was necessary since systematically collected data on these interactions and their relative frequencies were not available. Data gaps in emerging infectious disease epidemiology and transmission still remain, particularly regarding reservoirs. This flexible framework could, however, add new information such as quantitative measures of risk factors,<xref rid="bib63" ref-type="bibr">63</xref>, <xref rid="bib64" ref-type="bibr">64</xref> or include alternative modelling approaches<xref rid="bib65" ref-type="bibr"><sup>65</sup></xref> where appropriate, when such assessments become more geographically comprehensive. Importantly, uncertainty at all stages can be propagated and included in estimates. To maximise generalisability, we were unable to include some pathogen-specific countermeasures. For instance, the high rankings of districts in Uganda and the Democratic Republic of the Congo do not account for historical viral haemorrhagic fever outbreaks in these locations<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> and the sophisticated response systems now present, which will help offset some of the outbreak potential identified by this framework. Such response blueprints or experiences, however, can be referenced and replicated by other at-risk countries, including pre-emptive surveys of bat populations in Ghana,<xref rid="bib66" ref-type="bibr"><sup>66</sup></xref> strategies to overcome logistical surveillance challenges used in Uganda,<xref rid="bib60" ref-type="bibr"><sup>60</sup></xref> or recognition of where existing infrastructure could be co-opted, such as polio teams in Nigeria.<xref rid="bib67" ref-type="bibr"><sup>67</sup></xref></p><p id="para300">Use of rankings versus absolute values meant that although comparative statements can be made, definitive statements of risk are harder. Given the evidence base currently available, we are able to identify potential spillover locations in a data-driven manner; however, such statements are not possible for stage 2 and 3 in the absence of more outbreak-specific information. For future iterations, parameterisation of outbreak receptivity using historical outbreaks could allow for this, and could also be used to weight the relative effect of factors. By leveraging the full history of outbreaks, these data will also provide a mechanism for formally validating the framework. When expanding to new regions, this ability to parameterise differences in factors will allow for regional variations to be considered. Rankings are also sensitive to estimated parameters such as the suitability thresholds defining risk at stage 1, which leads to inconsistent at-risk admin 2 level definitions based on varying thresholds (supplementary materials). Such variation is incorporated and reflected in broader uncertainty intervals. In spite of this fact, however, districts such as Gu&#x000e9;ck&#x000e9;dou (the epicentre of the western African Ebola virus disease outbreak) remain in the 98th percentile of districts with high epidemic potential for Ebola virus disease, indicating that this approach can indeed provide valuable information on epidemic potential.</p><p id="para310">The appropriateness of factors in approximating for these processes is open to debate, as a trade-off between the geographic completeness and epidemiological relevance of data that was needed for inclusion. For instance, more appropriate proxies for local expenditure on health care beyond percentage of total gross domestic product could be leveraged as this information becomes increasingly available.<xref rid="bib68" ref-type="bibr"><sup>68</sup></xref> Similarly, response time might not be solely dependent on travel infrastructure being present, but also its quality and year-round availability. With continued efforts to improve existing data resources or use geostatistical approaches to increase their spatial resolution,<xref rid="bib69" ref-type="bibr">69</xref>, <xref rid="bib70" ref-type="bibr">70</xref> these improved covariates can all be included in future iterations. Increasing the number of subnational covariates will also result in greater variation between districts within a country (supplementary materials), and is therefore particularly important when considering using such approaches to evaluate heterogeneity within a specific country. Additional pathogens will require other covariates to be considered. For instance, existing niche mapping approaches have been restricted to those pathogens strongly affected by environmental factors, whereas additional pathogens will necessitate quantification of an increasing number of socioeconomic factors.<xref rid="bib71" ref-type="bibr">71</xref>, <xref rid="bib72" ref-type="bibr">72</xref> The modular nature of this approach, however, allows for their inclusion should they become available.</p><p id="para320">Pathogens will continue to emerge and providing a rational and informed mechanism for the identification and prioritisation of regions for improvement and assistance across the world is therefore crucial. As demonstrated with African viral haemorrhagic fevers, this framework presents pandemic potential as distinct, yet interconnected stages, and allows for specific interventions to be tailored to locations where it is likely to have the greatest effect before the next epidemic. In moving to a more proactive consideration of these pathogens and regional variation in vulnerabilities, this analysis complements global health security ambitions and contributes to the larger discussion of where to focus limited resources in preparation for an epidemic of these rare, yet potentially devastating, pathogens.</p></sec></body><back><ref-list id="bibl10"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sbref10"><person-group person-group-type="author"><collab>WHO Ebola Response Team</collab></person-group><article-title>After Ebola in West Africa&#x02014;unpredictable risks, preventable epidemics</article-title><source>N Engl J Med</source><volume>375</volume><year>2016</year><fpage>587</fpage><lpage>596</lpage><pub-id pub-id-type="pmid">27509108</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sbref20"><person-group person-group-type="author"><name><surname>Piot</surname><given-names>P</given-names></name></person-group><article-title>Ebola's perfect storm</article-title><source>Science</source><volume>345</volume><year>2014</year><fpage>1221</fpage><pub-id pub-id-type="pmid">25214580</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sbref30"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>DE</given-names></name><name><surname>Black</surname><given-names>S</given-names></name><name><surname>Rappuoli</surname><given-names>R</given-names></name></person-group><article-title>Emerging infectious diseases: a proactive approach</article-title><source>Proc Natl Acad Sci</source><volume>114</volume><year>2017</year><fpage>4055</fpage><lpage>4059</lpage><pub-id pub-id-type="pmid">28396438</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sbref40"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>CA</given-names></name><name><surname>Kasson</surname><given-names>PM</given-names></name><name><surname>Donis</surname><given-names>RO</given-names></name></person-group><article-title>Improving pandemic influenza risk assessment</article-title><source>Elife</source><volume>3</volume><year>2014</year><fpage>e03883</fpage><pub-id pub-id-type="pmid">25321142</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sbref50"><person-group person-group-type="author"><name><surname>Sands</surname><given-names>P</given-names></name><name><surname>Mundaca-Shah</surname><given-names>C</given-names></name><name><surname>Dzau</surname><given-names>VJ</given-names></name></person-group><article-title>The neglected dimension of global security&#x02014;a framework for countering infectious-disease crises</article-title><source>N Engl J Med</source><volume>374</volume><year>2016</year><fpage>1281</fpage><lpage>1287</lpage><pub-id pub-id-type="pmid">26761419</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sbref60"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>S</given-names></name><name><surname>Leigh</surname><given-names>J</given-names></name><name><surname>Woskie</surname><given-names>L</given-names></name></person-group><article-title>Post-Ebola reforms: ample analysis, inadequate action</article-title><source>BMJ</source><volume>356</volume><year>2017</year><fpage>j280</fpage><pub-id pub-id-type="pmid">28115316</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sbref70"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>S</given-names></name><name><surname>Sridhar</surname><given-names>D</given-names></name><name><surname>Pate</surname><given-names>MA</given-names></name></person-group><article-title>Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard&#x02013;LSHTM Independent Panel on the Global Response to Ebola</article-title><source>Lancet</source><volume>386</volume><year>2015</year><fpage>2204</fpage><lpage>2221</lpage><pub-id pub-id-type="pmid">26615326</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sbref80"><person-group person-group-type="author"><name><surname>Kieny</surname><given-names>MP</given-names></name><name><surname>Dovlo</surname><given-names>D</given-names></name></person-group><article-title>Beyond Ebola: a new agenda for resilient health systems</article-title><source>Lancet</source><volume>385</volume><year>2015</year><fpage>91</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">25706456</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sbref90"><person-group person-group-type="author"><name><surname>Dieleman</surname><given-names>JL</given-names></name><name><surname>Schneider</surname><given-names>MT</given-names></name><name><surname>Haakenstad</surname><given-names>A</given-names></name></person-group><article-title>Development assistance for health: past trends, associations, and the future of international financial flows for health</article-title><source>Lancet</source><volume>387</volume><year>2016</year><fpage>2536</fpage><lpage>2544</lpage><pub-id pub-id-type="pmid">27086170</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sbref100"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>KE</given-names></name><name><surname>Patel</surname><given-names>NG</given-names></name><name><surname>Levy</surname><given-names>MA</given-names></name></person-group><article-title>Global trends in emerging infectious diseases</article-title><source>Nature</source><volume>451</volume><year>2008</year><fpage>990</fpage><lpage>993</lpage><pub-id pub-id-type="pmid">18288193</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sbref110"><person-group person-group-type="author"><name><surname>Paez-Espino</surname><given-names>D</given-names></name><name><surname>Eloe-Fadrosh</surname><given-names>EA</given-names></name><name><surname>Pavlopoulos</surname><given-names>GA</given-names></name></person-group><article-title>Uncovering Earth's virome</article-title><source>Nature</source><volume>536</volume><year>2016</year><fpage>425</fpage><lpage>430</lpage><pub-id pub-id-type="pmid">27533034</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sbref120"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>M</given-names></name><name><surname>Gelfeld</surname><given-names>B</given-names></name><name><surname>Okunogbe</surname><given-names>A</given-names></name><name><surname>Paul</surname><given-names>C</given-names></name></person-group><article-title>Identifying future disease hotspots: infectious disease vulnerability index</article-title><source>Rand Health Q</source><volume>6</volume><year>2017</year><fpage>5</fpage></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sbref130"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>AM</given-names></name><name><surname>Pulliam</surname><given-names>JT</given-names></name><name><surname>Alexander</surname><given-names>LW</given-names></name><name><surname>Park</surname><given-names>AW</given-names></name><name><surname>Rohani</surname><given-names>P</given-names></name><name><surname>Drake</surname><given-names>JM</given-names></name></person-group><article-title>Spatial spread of the West Africa Ebola epidemic</article-title><source>R Soc Open Sci</source><volume>3</volume><year>2016</year><fpage>160294</fpage><pub-id pub-id-type="pmid">27853607</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sbref140"><person-group person-group-type="author"><name><surname>Bogoch</surname><given-names>II</given-names></name><name><surname>Brady</surname><given-names>OJ</given-names></name><name><surname>Kraemer</surname><given-names>MUG</given-names></name></person-group><article-title>Anticipating the international spread of Zika virus from Brazil</article-title><source>Lancet</source><volume>387</volume><year>2016</year><fpage>335</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">26777915</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sbref150"><person-group person-group-type="author"><name><surname>Faria</surname><given-names>NR</given-names></name><name><surname>Azevedo</surname><given-names>RdS</given-names></name><name><surname>Kraemer</surname><given-names>MUG</given-names></name></person-group><article-title>Zika virus in the Americas: early epidemiological and genetic findings</article-title><source>Science</source><volume>352</volume><year>2016</year><fpage>345</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">27013429</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sbref160"><person-group person-group-type="author"><name><surname>Camacho</surname><given-names>A</given-names></name><name><surname>Kucharski</surname><given-names>A</given-names></name><name><surname>Aki-Sawyerr</surname><given-names>Y</given-names></name></person-group><article-title>Temporal changes in Ebola transmission in Sierra Leone and implications for control requirements: a real-time modelling study</article-title><source>PLoS Curr</source><volume>7</volume><year>2015</year><comment>10.1371/currents.outbreaks.406ae55e83ec0b5193e3085.</comment></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sbref170"><person-group person-group-type="author"><name><surname>Lo Iacono</surname><given-names>G</given-names></name><name><surname>Cunningham</surname><given-names>AA</given-names></name><name><surname>Fichet-Calvet</surname><given-names>E</given-names></name></person-group><article-title>A unified framework for the infection dynamics of zoonotic spillover and spread</article-title><source>PLoS Negl Trop Dis</source><volume>10</volume><year>2016</year><fpage>e0004957</fpage><pub-id pub-id-type="pmid">27588425</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sbref180"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>R</given-names></name><name><surname>Hickson</surname><given-names>RI</given-names></name><name><surname>McVernon</surname><given-names>J</given-names></name></person-group><article-title>Model-informed risk assessment and decision making for an emerging infectious disease in the Asia-Pacific region</article-title><source>PLoS Negl Trop Dis</source><volume>10</volume><year>2016</year><fpage>e0005018</fpage><pub-id pub-id-type="pmid">27661978</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sbref190"><person-group person-group-type="author"><name><surname>Bannister</surname><given-names>B</given-names></name></person-group><article-title>Viral haemorrhagic fevers imported into non-endemic countries: risk assessment and management</article-title><source>Br Med Bull</source><volume>95</volume><year>2010</year><fpage>193</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">20682627</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sbref200"><person-group person-group-type="author"><name><surname>Messina</surname><given-names>JP</given-names></name><name><surname>Pigott</surname><given-names>DM</given-names></name><name><surname>Golding</surname><given-names>N</given-names></name></person-group><article-title>The global distribution of Crimean&#x02013;Congo hemorrhagic fever</article-title><source>Trans R Soc Trop Med Hyg</source><volume>109</volume><year>2015</year><fpage>503</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">26142451</pub-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sbref210"><person-group person-group-type="author"><name><surname>Messina</surname><given-names>JP</given-names></name><name><surname>Pigott</surname><given-names>DM</given-names></name><name><surname>Duda</surname><given-names>KA</given-names></name></person-group><article-title>A global compendium of human Crimean&#x02013;Congo haemorrhagic fever virus occurrence</article-title><source>Sci Data</source><volume>2</volume><year>2015</year><fpage>150016</fpage><pub-id pub-id-type="pmid">25977820</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sbref220"><person-group person-group-type="author"><name><surname>Pigott</surname><given-names>DM</given-names></name><name><surname>Millear</surname><given-names>AI</given-names></name><name><surname>Earl</surname><given-names>L</given-names></name></person-group><article-title>Updates to the zoonotic niche map of Ebola virus disease in Africa</article-title><source>Elife</source><volume>5</volume><year>2016</year><fpage>e16412</fpage><pub-id pub-id-type="pmid">27414263</pub-id></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sbref230"><person-group person-group-type="author"><name><surname>Mylne</surname><given-names>A</given-names></name><name><surname>Brady</surname><given-names>OJ</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name></person-group><article-title>A comprehensive database of the geographic spread of past human Ebola outbreaks</article-title><source>Sci Data</source><volume>1</volume><year>2014</year><fpage>140042</fpage><pub-id pub-id-type="pmid">25984346</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sbref240"><person-group person-group-type="author"><name><surname>Mylne</surname><given-names>AQN</given-names></name><name><surname>Pigott</surname><given-names>DM</given-names></name><name><surname>Longbottom</surname><given-names>J</given-names></name></person-group><article-title>Mapping the zoonotic niche of Lassa fever in Africa</article-title><source>Trans R Soc Trop Med Hyg</source><volume>109</volume><year>2015</year><fpage>483</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">26085474</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sbref250"><person-group person-group-type="author"><name><surname>Pigott</surname><given-names>DM</given-names></name><name><surname>Golding</surname><given-names>N</given-names></name><name><surname>Mylne</surname><given-names>A</given-names></name></person-group><article-title>Mapping the zoonotic niche of Marburg virus disease in Africa</article-title><source>Trans R Soc Trop Med Hyg</source><volume>109</volume><year>2015</year><fpage>366</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">25820266</pub-id></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sbref260"><person-group person-group-type="author"><name><surname>Tatem</surname><given-names>AJ</given-names></name></person-group><article-title>WorldPop, open data for spatial demography</article-title><source>Sci Data</source><volume>4</volume><year>2017</year><fpage>170004</fpage><pub-id pub-id-type="pmid">28140397</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="other" id="sbref270"><person-group person-group-type="author"><collab>World Bank</collab></person-group><article-title>The Worldwide Governance Indicators (WGI) Project&#x02014;methodology</article-title><ext-link ext-link-type="uri" xlink:href="http://info.worldbank.org/governance/wgi/index.aspx#doc" id="interrefs40">http://info.worldbank.org/governance/wgi/index.aspx#doc</ext-link><year>2015</year><comment>(accessed June 7, 2016).</comment></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="other" id="sbref280"><person-group person-group-type="author"><collab>Transparency International</collab></person-group><article-title>The 2015 Corruption Perceptions Index</article-title><ext-link ext-link-type="uri" xlink:href="http://www.transparency.org/cpi2015/" id="interrefs50">http://www.transparency.org/cpi2015/</ext-link><year>2016</year><comment>(accessed May 19, 2016).</comment></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="book" id="sbref290"><person-group person-group-type="author"><collab>Institute for Health Metrics and Evaluation</collab></person-group><source>Financing Global Health 2015: development assistance steady on the path to new Global Goals</source><year>2016</year><publisher-name>Institute for Health Metrics and Evaluation</publisher-name><publisher-loc>Seattle, WA</publisher-loc></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="other" id="sbref300"><person-group person-group-type="author"><collab>Armed Conflict Location &#x00026; Event Data Project</collab></person-group><article-title>Armed conflict location &#x00026; event data project version 6 (1997&#x02013;2015)</article-title><ext-link ext-link-type="uri" xlink:href="http://www.acleddata.com/data/version-6-data-1997-2015/" id="interrefs60">http://www.acleddata.com/data/version-6-data-1997-2015/</ext-link><year>2016</year><comment>(accessed May 19, 2016).</comment></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="other" id="sbref310"><person-group person-group-type="author"><collab>Institute for Health Metrics and Evaluation</collab></person-group><article-title>Global Educational Attainment 1970&#x02013;2015</article-title><ext-link ext-link-type="uri" xlink:href="http://ghdx.healthdata.org/record/global-educational-attainment-1970-2015" id="interrefs70">http://ghdx.healthdata.org/record/global-educational-attainment-1970-2015</ext-link><year>2015</year><comment>(accessed June 10, 2016).</comment></element-citation></ref><ref id="bib32"><label>32</label><mixed-citation publication-type="other" id="oref10">World Bank. Internet users (per 100 people). 2015. <ext-link ext-link-type="uri" xlink:href="https://web.archive.org/web/20160609192115" id="interrefs80">https://web.archive.org/web/20160609192115</ext-link>/<ext-link ext-link-type="uri" xlink:href="http://data.worldbank.org/indicator/IT.NET.USER.P2" id="interrefs90">http://data.worldbank.org/indicator/IT.NET.USER.P2</ext-link> (accessed June 10, 2016).</mixed-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="other" id="sbref320"><person-group person-group-type="author"><collab>World Bank</collab></person-group><article-title>Mobile cellular subscriptions (per 100 people)</article-title><ext-link ext-link-type="uri" xlink:href="http://data.worldbank.org/indicator/IT.CEL.SETS.P2" id="interrefs100">http://data.worldbank.org/indicator/IT.CEL.SETS.P2</ext-link><year>2015</year><comment>(accessed June 7, 2016).</comment></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="other" id="sbref330"><person-group person-group-type="author"><collab>World Bank</collab></person-group><article-title>Access to electricity (% of population)</article-title><ext-link ext-link-type="uri" xlink:href="http://data.worldbank.org/indicator/EG.ELC.ACCS.ZS" id="interrefs110">http://data.worldbank.org/indicator/EG.ELC.ACCS.ZS</ext-link><year>2015</year><comment>(accessed June 7, 2016).</comment></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="other" id="sbref340"><person-group person-group-type="author"><collab>NASA Socioeconomic Data and Applications Center (SEDAC)</collab></person-group><article-title>Global Rural-Urban Mapping Project</article-title><ext-link ext-link-type="uri" xlink:href="http://sedac.ciesin.columbia.edu/data/collection/grump-v1/about-us" id="interrefs120">http://sedac.ciesin.columbia.edu/data/collection/grump-v1/about-us</ext-link><comment>(accessed Dec 3, 2015).</comment></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="other" id="sbref350"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>A</given-names></name></person-group><article-title>Estimated travel time to the nearest city of 50,000 or more people in year 2000</article-title><ext-link ext-link-type="uri" xlink:href="http://forobs.jrc.ec.europa.eu/products/gam/" id="interrefs130">http://forobs.jrc.ec.europa.eu/products/gam/</ext-link><year>2008</year><comment>(accessed April 3, 2017).</comment></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sbref360"><person-group person-group-type="author"><name><surname>Pullan</surname><given-names>RL</given-names></name><name><surname>Freeman</surname><given-names>MC</given-names></name><name><surname>Gething</surname><given-names>PW</given-names></name><name><surname>Brooker</surname><given-names>SJ</given-names></name></person-group><article-title>Geographical inequalities in use of improved drinking water supply and sanitation across Sub-Saharan Africa: mapping and spatial analysis of cross-sectional survey data</article-title><source>PLoS Med</source><volume>11</volume><year>2014</year><fpage>e1001626</fpage><pub-id pub-id-type="pmid">24714528</pub-id></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sbref370"><person-group person-group-type="author"><collab>GBD 2015 Risk Factors Collaborators</collab></person-group><article-title>Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990&#x02013;2015: a systematic analysis for the Global Burden of Disease Study 2015</article-title><source>Lancet</source><volume>388</volume><year>2016</year><fpage>1659</fpage><lpage>1724</lpage><pub-id pub-id-type="pmid">27733284</pub-id></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="other" id="sbref380"><person-group person-group-type="author"><collab>WHO</collab></person-group><article-title>WHO UNICEF review of national immunization coverage, 1980&#x02013;2014</article-title><ext-link ext-link-type="uri" xlink:href="http://apps.who.int/immunization_monitoring/globalsummary/wucoveragecountrylist.html" id="interrefs140">http://apps.who.int/immunization_monitoring/globalsummary/wucoveragecountrylist.html</ext-link><year>2016</year><comment>(accessed July 21, 2016).</comment></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sbref390"><person-group person-group-type="author"><collab>GBD 2015 Disease and Injury Incidence and Prevalence Collaborators</collab></person-group><article-title>Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990&#x02013;2015: a systematic analysis for the Global Burden of Disease Study 2015</article-title><source>Lancet</source><volume>388</volume><year>2016</year><fpage>1545</fpage><lpage>1602</lpage><pub-id pub-id-type="pmid">27733282</pub-id></element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sbref400"><person-group person-group-type="author"><collab>GBD 2015 DALYs and HALE Collaborators</collab></person-group><article-title>Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990&#x02013;2015: a systematic analysis for the Global Burden of Disease Study 2015</article-title><source>Lancet</source><volume>388</volume><year>2016</year><fpage>1603</fpage><lpage>1658</lpage><pub-id pub-id-type="pmid">27733283</pub-id></element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="other" id="sbref410"><person-group person-group-type="author"><collab>WHO</collab></person-group><article-title>Health expenditure ratios, by country, 1995&#x02013;2014</article-title><ext-link ext-link-type="uri" xlink:href="http://apps.who.int/gho/data/node.main.75?lang=en" id="interrefs150">http://apps.who.int/gho/data/node.main.75?lang=en</ext-link><year>2016</year><comment>(accessed July 21, 2016).</comment></element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="journal" id="sbref420"><person-group person-group-type="author"><name><surname>Golding</surname><given-names>N</given-names></name><name><surname>Burstein</surname><given-names>R</given-names></name><name><surname>Longbottom</surname><given-names>J</given-names></name></person-group><article-title>Mapping under-5 and neonatal mortality in Africa, 2000&#x02013;15: a baseline analysis for the Sustainable Development Goals</article-title><source>Lancet</source><year>2017</year><comment>published online Sept 25.</comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(17)31758-0" id="interrefs160">http://dx.doi.org/10.1016/S0140-6736(17)31758-0</ext-link></element-citation></ref><ref id="bib44"><label>44</label><element-citation publication-type="book" id="sbref430"><person-group person-group-type="author"><name><surname>De Groeve</surname><given-names>T</given-names></name><name><surname>Poljansek</surname><given-names>K</given-names></name><name><surname>Vernaccini</surname><given-names>L</given-names></name></person-group><source>Index for Risk Management&#x02014;INFORM&#x02014;concept and methodology version 2014</source><year>2014</year><publisher-name>Publications Office of the European Union</publisher-name><publisher-loc>Luxembourg</publisher-loc></element-citation></ref><ref id="bib45"><label>45</label><element-citation publication-type="other" id="sbref440"><person-group person-group-type="author"><collab>Index for Risk Management</collab></person-group><article-title>Using INFORM to assess crisis and disaster risk within a country or region</article-title><ext-link ext-link-type="uri" xlink:href="http://www.inform-index.org/Portals/0/InfoRM/2016/INFORM%20Subnational%20Guidance%20Note.pdf" id="interrefs170">http://www.inform-index.org/Portals/0/InfoRM/2016/INFORM%20Subnational%20Guidance%20Note.pdf</ext-link><year>2015</year><comment>(accessed Nov 6, 2015).</comment></element-citation></ref><ref id="bib46"><label>46</label><element-citation publication-type="book" id="sbref450"><person-group person-group-type="author"><collab>Food and Agricultural Organization of the United Nations</collab></person-group><source>The Global Administrative Unite Layers (GAUL): technical aspects</source><year>2008</year><publisher-name>Food and Agriculture Organization of the United Nations, EC-FAO Food Security Programme</publisher-name><publisher-loc>Rome</publisher-loc></element-citation></ref><ref id="bib47"><label>47</label><element-citation publication-type="journal" id="sbref460"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>GA</given-names></name><name><surname>Alkema</surname><given-names>L</given-names></name><name><surname>Black</surname><given-names>RE</given-names></name></person-group><article-title>Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement</article-title><source>Lancet</source><volume>388</volume><year>2016</year><fpage>e19</fpage><lpage>e23</lpage><pub-id pub-id-type="pmid">27371184</pub-id></element-citation></ref><ref id="bib48"><label>48</label><element-citation publication-type="journal" id="sbref470"><person-group person-group-type="author"><name><surname>Pigott</surname><given-names>DM</given-names></name><name><surname>Golding</surname><given-names>N</given-names></name><name><surname>Mylne</surname><given-names>A</given-names></name></person-group><article-title>Mapping the zoonotic niche of Ebola virus disease in Africa</article-title><source>Elife</source><volume>3</volume><year>2014</year><fpage>e04395</fpage><pub-id pub-id-type="pmid">25201877</pub-id></element-citation></ref><ref id="bib49"><label>49</label><element-citation publication-type="journal" id="sbref480"><person-group person-group-type="author"><name><surname>Elith</surname><given-names>J</given-names></name><name><surname>Leathwick</surname><given-names>JR</given-names></name><name><surname>Hastie</surname><given-names>T</given-names></name></person-group><article-title>A working guide to boosted regression trees</article-title><source>J Anim Ecol</source><volume>77</volume><year>2008</year><fpage>802</fpage><lpage>813</lpage><pub-id pub-id-type="pmid">18397250</pub-id></element-citation></ref><ref id="bib50"><label>50</label><element-citation publication-type="journal" id="sbref490"><person-group person-group-type="author"><name><surname>Elith</surname><given-names>J</given-names></name><name><surname>Leathwick</surname><given-names>JR</given-names></name></person-group><article-title>Species distribution models: ecological explanation and prediction across space and time</article-title><source>Annu Rev Ecol Evol Syst</source><volume>40</volume><year>2009</year><fpage>677</fpage><lpage>697</lpage></element-citation></ref><ref id="bib51"><label>51</label><element-citation publication-type="journal" id="sbref500"><person-group person-group-type="author"><name><surname>Cantor</surname><given-names>SB</given-names></name><name><surname>Sun</surname><given-names>CC</given-names></name><name><surname>Tortolero-Luna</surname><given-names>G</given-names></name><name><surname>Richards-Kortum</surname><given-names>R</given-names></name><name><surname>Follen</surname><given-names>M</given-names></name></person-group><article-title>A comparison of C/B ratios from studies using receiver operating characteristic curve analysis</article-title><source>J Clin Epidemiol</source><volume>52</volume><year>1999</year><fpage>885</fpage><lpage>892</lpage><pub-id pub-id-type="pmid">10529029</pub-id></element-citation></ref><ref id="bib52"><label>52</label><element-citation publication-type="journal" id="sbref510"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Berry</surname><given-names>PM</given-names></name><name><surname>Dawson</surname><given-names>TP</given-names></name><name><surname>Pearson</surname><given-names>RG</given-names></name></person-group><article-title>Selecting thresholds of occurrence in the prediction of species distributions</article-title><source>Ecography</source><volume>28</volume><year>2005</year><fpage>385</fpage><lpage>393</lpage></element-citation></ref><ref id="bib53"><label>53</label><element-citation publication-type="other" id="sbref520"><person-group person-group-type="author"><collab>WorldPop Project</collab></person-group><article-title>Gridded population surface of Africa</article-title><ext-link ext-link-type="uri" xlink:href="http://www.worldpop.org.uk/data/summary/?doi=10.5258/SOTON/WP00004" id="interrefs180">http://www.worldpop.org.uk/data/summary/?doi=10.5258/SOTON/WP00004</ext-link><year>2015</year><comment>(accessed Nov 6, 2015).</comment></element-citation></ref><ref id="bib54"><label>54</label><element-citation publication-type="journal" id="sbref530"><person-group person-group-type="author"><name><surname>Raleigh</surname><given-names>C</given-names></name><name><surname>Linke</surname><given-names>A</given-names></name><name><surname>Hegre</surname><given-names>H</given-names></name><name><surname>Karlsen</surname><given-names>J</given-names></name></person-group><article-title>Introducing ACLED: an armed conflict location and event dataset: special data feature</article-title><source>J Peace Res</source><volume>47</volume><year>2010</year><fpage>651</fpage><lpage>660</lpage></element-citation></ref><ref id="bib55"><label>55</label><element-citation publication-type="journal" id="sbref540"><person-group person-group-type="author"><name><surname>Box</surname><given-names>GEP</given-names></name><name><surname>Cox</surname><given-names>DR</given-names></name></person-group><article-title>An analysis of transformations</article-title><source>J R Stat Soc Ser B</source><volume>26</volume><year>1964</year><fpage>211</fpage><lpage>252</lpage></element-citation></ref><ref id="bib56"><label>56</label><element-citation publication-type="journal" id="sbref550"><person-group person-group-type="author"><name><surname>Paruolo</surname><given-names>P</given-names></name><name><surname>Saisana</surname><given-names>M</given-names></name><name><surname>Saltelli</surname><given-names>A</given-names></name></person-group><article-title>Ratings and rankings: voodoo or science?</article-title><source>J R Stat Soc Ser A</source><volume>176</volume><year>2013</year><fpage>609</fpage><lpage>634</lpage></element-citation></ref><ref id="bib57"><label>57</label><element-citation publication-type="journal" id="sbref560"><person-group person-group-type="author"><name><surname>Saltelli</surname><given-names>A</given-names></name><name><surname>Tarantola</surname><given-names>S</given-names></name></person-group><article-title>On the relative importance of input factors in mathematical models</article-title><source>J Am Stat Assoc</source><volume>97</volume><year>2002</year><fpage>702</fpage><lpage>709</lpage></element-citation></ref><ref id="bib58"><label>58</label><element-citation publication-type="journal" id="sbref570"><person-group person-group-type="author"><name><surname>Bogoch</surname><given-names>II</given-names></name><name><surname>Creatore</surname><given-names>MI</given-names></name><name><surname>Cetron</surname><given-names>MS</given-names></name></person-group><article-title>Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak</article-title><source>Lancet</source><volume>385</volume><year>2014</year><fpage>29</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">25458732</pub-id></element-citation></ref><ref id="bib59"><label>59</label><element-citation publication-type="journal" id="sbref580"><person-group person-group-type="author"><name><surname>Morozoff</surname><given-names>C</given-names></name><name><surname>Pigott</surname><given-names>DM</given-names></name><name><surname>Sankoh</surname><given-names>O</given-names></name><name><surname>Laney</surname><given-names>S</given-names></name><name><surname>Hay</surname><given-names>SI</given-names></name></person-group><article-title>Enhancement of Ebola preparedness across Africa</article-title><source>Emerg Infect Dis</source><volume>22</volume><year>2016</year><fpage>e160642</fpage></element-citation></ref><ref id="bib60"><label>60</label><element-citation publication-type="journal" id="sbref590"><person-group person-group-type="author"><name><surname>Borchert</surname><given-names>M</given-names></name><name><surname>Mutyaba</surname><given-names>I</given-names></name><name><surname>Van Kerkhove</surname><given-names>MD</given-names></name></person-group><article-title>Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned</article-title><source>BMC Infect Dis</source><volume>11</volume><year>2011</year><fpage>357</fpage><pub-id pub-id-type="pmid">22204600</pub-id></element-citation></ref><ref id="bib61"><label>61</label><element-citation publication-type="journal" id="sbref600"><person-group person-group-type="author"><name><surname>Skrip</surname><given-names>LA</given-names></name><name><surname>Galvani</surname><given-names>AP</given-names></name><name><surname>Agnandji</surname><given-names>S</given-names></name></person-group><article-title>Next steps for Ebola vaccination: deployment in non- epidemic, high-risk settings</article-title><source>PLoS Negl Trop Dis</source><volume>10</volume><year>2016</year><fpage>e0004802</fpage><pub-id pub-id-type="pmid">27537602</pub-id></element-citation></ref><ref id="bib62"><label>62</label><element-citation publication-type="journal" id="sbref610"><person-group person-group-type="author"><name><surname>Merler</surname><given-names>S</given-names></name><name><surname>Ajelli</surname><given-names>M</given-names></name><name><surname>Fumanelli</surname><given-names>L</given-names></name></person-group><article-title>Containing Ebola at the source with ring vaccination</article-title><source>PLoS Negl Trop Dis</source><volume>10</volume><year>2016</year><fpage>e0005093</fpage><pub-id pub-id-type="pmid">27806049</pub-id></element-citation></ref><ref id="bib63"><label>63</label><element-citation publication-type="journal" id="sbref620"><person-group person-group-type="author"><name><surname>Fa</surname><given-names>JE</given-names></name><name><surname>Olivero</surname><given-names>J</given-names></name><name><surname>Farf&#x000e1;n</surname><given-names>MA</given-names></name></person-group><article-title>Differences between pygmy and non-pygmy hunting in Congo basin forests</article-title><source>PLoS One</source><volume>11</volume><year>2016</year><fpage>e0161703</fpage><pub-id pub-id-type="pmid">27589384</pub-id></element-citation></ref><ref id="bib64"><label>64</label><element-citation publication-type="journal" id="sbref630"><person-group person-group-type="author"><name><surname>Woldehanna</surname><given-names>S</given-names></name><name><surname>Zimicki</surname><given-names>S</given-names></name></person-group><article-title>An expanded One Health model: integrating social science and One Health to inform study of the human-animal interface</article-title><source>Soc Sci Med</source><volume>129</volume><year>2015</year><fpage>87</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">25464873</pub-id></element-citation></ref><ref id="bib65"><label>65</label><element-citation publication-type="journal" id="sbref640"><person-group person-group-type="author"><name><surname>Redding</surname><given-names>DW</given-names></name><name><surname>Moses</surname><given-names>LM</given-names></name><name><surname>Cunningham</surname><given-names>AA</given-names></name><name><surname>Wood</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>KE</given-names></name></person-group><article-title>Environmental-mechanistic modelling of the impact of global change on human zoonotic disease emergence: a case study of Lassa fever</article-title><source>Methods Ecol Evol</source><volume>7</volume><year>2016</year><fpage>646</fpage><lpage>655</lpage></element-citation></ref><ref id="bib66"><label>66</label><element-citation publication-type="journal" id="sbref650"><person-group person-group-type="author"><name><surname>Hayman</surname><given-names>DTS</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Crameri</surname><given-names>G</given-names></name></person-group><article-title>Ebola virus antibodies in fruit bats, Ghana, West Africa</article-title><source>Emerg Infect Dis</source><volume>18</volume><year>2012</year><fpage>1207</fpage><lpage>1209</lpage><pub-id pub-id-type="pmid">22710257</pub-id></element-citation></ref><ref id="bib67"><label>67</label><element-citation publication-type="journal" id="sbref660"><person-group person-group-type="author"><name><surname>Vaz</surname><given-names>RG</given-names></name><name><surname>Mkanda</surname><given-names>P</given-names></name><name><surname>Banda</surname><given-names>R</given-names></name></person-group><article-title>The role of the polio program infrastructure in response to Ebola virus disease outbreak in Nigeria 2014</article-title><source>J Infect Dis</source><volume>213</volume><issue>suppl 3</issue><year>2016</year><fpage>S140</fpage><lpage>S146</lpage><pub-id pub-id-type="pmid">26908718</pub-id></element-citation></ref><ref id="bib68"><label>68</label><element-citation publication-type="journal" id="sbref670"><person-group person-group-type="author"><name><surname>Marty</surname><given-names>R</given-names></name><name><surname>Dolan</surname><given-names>CB</given-names></name><name><surname>Leu</surname><given-names>M</given-names></name><name><surname>Runfola</surname><given-names>D</given-names></name></person-group><article-title>Taking the health aid debate to the subnational level: the impact and allocation of foreign health aid in Malawi</article-title><source>BMJ Glob Health</source><volume>2</volume><year>2017</year><fpage>e000129</fpage></element-citation></ref><ref id="bib69"><label>69</label><element-citation publication-type="journal" id="sbref680"><person-group person-group-type="author"><name><surname>Bhatt</surname><given-names>S</given-names></name><name><surname>Weiss</surname><given-names>DJ</given-names></name><name><surname>Mappin</surname><given-names>B</given-names></name></person-group><article-title>Coverage and system efficiencies of insecticide-treated nets in Africa from 2000 to 2017</article-title><source>Elife</source><volume>4</volume><year>2015</year><fpage>e09672</fpage><pub-id pub-id-type="pmid">26714109</pub-id></element-citation></ref><ref id="bib70"><label>70</label><element-citation publication-type="journal" id="sbref690"><person-group person-group-type="author"><name><surname>Jean</surname><given-names>N</given-names></name><name><surname>Burke</surname><given-names>M</given-names></name><name><surname>Xie</surname><given-names>M</given-names></name><name><surname>Davis</surname><given-names>WM</given-names></name><name><surname>Lobell</surname><given-names>DB</given-names></name><name><surname>Ermon</surname><given-names>S</given-names></name></person-group><article-title>Combining satellite imagery and machine learning to predict poverty</article-title><source>Science</source><volume>353</volume><year>2016</year><fpage>790</fpage><lpage>794</lpage><pub-id pub-id-type="pmid">27540167</pub-id></element-citation></ref><ref id="bib71"><label>71</label><element-citation publication-type="journal" id="sbref700"><person-group person-group-type="author"><name><surname>Kraemer</surname><given-names>MUG</given-names></name><name><surname>Hay</surname><given-names>SI</given-names></name><name><surname>Pigott</surname><given-names>DM</given-names></name><name><surname>Smith</surname><given-names>DL</given-names></name><name><surname>Wint</surname><given-names>GRW</given-names></name><name><surname>Golding</surname><given-names>N</given-names></name></person-group><article-title>Progress and challenges in infectious disease cartography</article-title><source>Trends Parasitol</source><volume>32</volume><year>2015</year><fpage>19</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">26604163</pub-id></element-citation></ref><ref id="bib72"><label>72</label><element-citation publication-type="journal" id="sbref710"><person-group person-group-type="author"><name><surname>Hay</surname><given-names>SI</given-names></name><name><surname>Battle</surname><given-names>KE</given-names></name><name><surname>Pigott</surname><given-names>DM</given-names></name></person-group><article-title>Global mapping of infectious disease</article-title><source>Philos Trans R Soc Lond B Biol Sci</source><volume>368</volume><year>2013</year><fpage>20120250</fpage><pub-id pub-id-type="pmid">23382431</pub-id></element-citation></ref></ref-list><ack id="ceack10"><sec><title>Acknowledgments</title><p>We acknowledge a meeting at the UK Department for International Development (DFID), which initiated the concept for this analysis. This work was funded by a grant from The Paul G Allen Ebola Program (grant 11878) to SIH, which also provided funding for DMP, AD, and CM. This work is also funded by a grant from the Bill &#x00026; Melinda Gates Foundation (grant OPP1093011), which funds DMP, AD, CM, IL, CLM, and SIH. SIH is also funded by a Senior Research Fellowship from the Wellcome Trust (grant 095066) and grants from the Bill &#x00026; Melinda Gates Foundation (grant OPP1132415). SIH has also received a grant from the Research for Health in Humanitarian Crises (R2HC) Programme, managed by ELHRA (grant 13468) and funded equally by the Wellcome Trust and DFID, which also supported NG and MUGK. AJT is supported by funding from the Bill &#x00026; Melinda Gates Foundation (grants OPP1106427, OPP1134076, OPP1094793), the Clinton Health Access Initiative and a Wellcome Trust Sustaining Health grant (106866/Z/15/Z). PWG is a Career Development Fellow (grant K00669X) jointly funded by the UK Medical research Council (MRC) and the DFID under the MRC/DFID Concordat agreement, also part of the EDCTP2 programme supported by the European Union, and receives support from the Bill &#x00026; Melinda Gates Foundation (grants OPP1068048, OPP1106023, OPP1132415). These grants also support DJW. OJB is funded by a Henry Wellcome Fellowship from the Wellcome Trust (206471/Z/17/Z). MUGK is supported by the Society in Science, The Branco Weiss Fellowship, administered by the ETH Zurich and acknowledges funding from a Training Grant from the National Institute of Child Health and Human Development (T32HD040128). The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services or of the institutions and companies affiliated with the authors. This work was supported in part through Battelle Memorial Institute's prime contract with the US National Institute of Allergy and Infectious Diseases (NIAID) under contract number HHSN272200700016I. A subcontractor to Battelle Memorial Institute who performed this work is JHK, an employee of Tunnell Government Services, Inc.</p></sec></ack><ack><title>Contributors</title><p>DMP and SIH conceived and planned the study, with input from LC, LV, NG, CLM, PH, JHK, PP, and OS. DMP, MUGK, IIB, KK, LE, CM, MHB, JPM, AQNM, CLM, FMS, SB, OJB, PWG, DJW, AJT, NG, and SIH created and processed environmental suitability datasets. DMP, AD, RCR, LE, IL, RB, DJW, and AJT collated outbreak receptivity data. SEB, IIB, and KK processed international flight data. DMP and AD processed all data for the final analysis with assistance from RCR processing outbreak receptivity data. IL produced output figures. All authors contributed to the analysis and interpretation of results. DMP wrote the first draft of the manuscript and all authors contributed to subsequent revisions.</p></ack><ack><title>Declarations of interests</title><p>We declare no competing interests.</p></ack></back></article>